MedTrace Logo

The Canadian E-PAraDiGM (Exercise Physical Activity and Diabetes Glucose Monitoring) Protocol

NCT02834689 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2019-10-03

No results posted yet for this study

Summary

Walking is encouraged for people with type 2 diabetes but there is little evidence that performing a bout of walking can improve glucose control. Furthermore, it is unknown how participant characteristics (e.g., age, sex, medications) impact the acute glucose responses to walking in people with type 2 diabetes. The primary purpose of this study is to examine how a standardized bout of walking impacts glucose control assessed over 24 hours using continuous glucose monitoring. A secondary purpose is to determine whether responses are influenced by age, sex, and medication use.

Conditions

  • Walking
  • Seated Control

Interventions

BEHAVIORAL

Walking

Walking on a treadmill at 3.5 METS for 50 minutes

BEHAVIORAL

Seated Control

Sitting for 50 minutes

Sponsors & Collaborators

  • University of Alberta

    collaborator OTHER

  • University of Calgary

    collaborator OTHER

  • McMaster University

    collaborator OTHER

  • Université de Sherbrooke

    collaborator OTHER

  • Centre Hospitalier de l'Université Laval

    collaborator UNKNOWN

  • Children's Hospital Research Institute of Manitoba

    collaborator OTHER

  • Medtronic

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-01
Primary Completion
2017-12-01
Completion
2017-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02834689 on ClinicalTrials.gov